As of 2025-08-15, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -5.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 83.28 mil USD. Apyx's TTM EBITDA according to its financial statements is -14.84 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 23.0x | 22.0x |
| Forward P/E multiples | 22.2x - 23.8x | 22.9x |
| Fair Price | (8.79) - (9.10) | (8.91) |
| Upside | -514.8% - -529.3% | -520.3% |
| Date | EV/EBITDA |
| 2025-08-13 | -6.20 |
| 2025-08-12 | -5.92 |
| 2025-08-11 | -5.89 |
| 2025-08-08 | -5.76 |
| 2025-08-07 | -5.20 |
| 2025-08-06 | -5.41 |
| 2025-08-05 | -5.08 |
| 2025-08-04 | -4.92 |
| 2025-08-01 | -4.67 |
| 2025-07-31 | -5.08 |
| 2025-07-30 | -5.05 |
| 2025-07-29 | -5.20 |
| 2025-07-28 | -6.38 |
| 2025-07-25 | -6.68 |
| 2025-07-24 | -6.25 |
| 2025-07-23 | -6.02 |
| 2025-07-22 | -5.94 |
| 2025-07-21 | -5.92 |
| 2025-07-18 | -5.97 |
| 2025-07-17 | -6.02 |
| 2025-07-16 | -5.54 |
| 2025-07-15 | -5.43 |
| 2025-07-14 | -5.23 |
| 2025-07-11 | -5.56 |
| 2025-07-10 | -5.71 |
| 2025-07-09 | -6.02 |
| 2025-07-08 | -6.25 |
| 2025-07-07 | -6.78 |
| 2025-07-03 | -6.04 |
| 2025-07-02 | -5.69 |
| 2025-07-01 | -5.92 |
| 2025-06-30 | -5.94 |
| 2025-06-27 | -5.71 |
| 2025-06-26 | -5.92 |
| 2025-06-25 | -5.05 |
| 2025-06-24 | -5.99 |
| 2025-06-23 | -5.31 |
| 2025-06-20 | -5.31 |
| 2025-06-18 | -4.57 |
| 2025-06-17 | -4.69 |
| 2025-06-16 | -4.95 |
| 2025-06-13 | -4.67 |
| 2025-06-12 | -4.58 |
| 2025-06-11 | -4.69 |
| 2025-06-10 | -4.85 |
| 2025-06-09 | -4.62 |
| 2025-06-06 | -4.47 |
| 2025-06-05 | -4.44 |
| 2025-06-04 | -4.44 |
| 2025-06-03 | -4.34 |